Acute inhalative exposure assessment: Derivation of guideline levels with special regard to sensitive subpopulations and time scaling

Toxicology

Volumn 214, Issue 3, 2005, Pages 256-267

  Mielke, Hans ^a   Gundert, Anna ^b   Abraham, Klaus ^a   Gundert Remy, Ursula ^a  

^a FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Acute exposure; Dichloromethane; Inhalation; Kinetic model; Risk assessment; Sensitive subpopulation

Indexed keywords

CHEMICAL WARFARE AGENT; DICHLOROMETHANE; VOLATILE ORGANIC COMPOUND;

AGE; AIR; ARTICLE; BIOLOGICAL MODEL; CONCENTRATION (PARAMETERS); DOCUMENTATION; DOSIMETRY; EXPOSURE; HUMAN; INTERMETHOD COMPARISON; KINETICS; MATHEMATICAL ANALYSIS; MATHEMATICS; METHODOLOGY; MODEL; NONHUMAN; PHYSICAL ACTIVITY; POPULATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SAMPLE; SPECIES DIFFERENCE; TIME; TOXICOKINETICS;

AIR POLLUTANTS; GUIDELINES; HAZARDOUS SUBSTANCES; HUMANS; INHALATION EXPOSURE; MAXIMUM ALLOWABLE CONCENTRATION; MODELS, THEORETICAL; PUBLIC HEALTH; RISK ASSESSMENT; THRESHOLD LIMIT VALUES; TIME FACTORS;

ANIMALIA;

EID: 26044439663     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2005.06.018     Document Type: Article

References (29)

1. K. Abraham, H. Mielke, W. Huisinga, and U. Gundert-Remy Elevated internal exposure of children in simulated acute inhalation of volatile organic compounds: effects of concentration and duration Arch. Toxicol. 79 2005 63 73
2. K. Abraham, H. Mielke, W. Huisinga, and U. Gundert-Remy Internal exposure of children by acute inhalation of volatile organic compounds: the influence of chemical properties on the child/adult concentration ratio Basic Clin. Pharmacol. Toxicol. 96 2005 242 243
3. AEGL-Committee Acute Exposure Guideline Levels for Selected Airborne Chemicals 2003 The National Academies Press Washington, DC
4. B.C. Allen, R.J. Kavlock, C.A. Kimmel, and E.M. Faustman Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels Fundam. Appl. Toxicol. 23 1994 487 495
5. M.E. Andersen, H.J. Clewell III, M.L. Gargas, F.A. Smith, and R.H. Reitz Physiologically based pharmacokinetics and the risk assessment process for methylene chloride Toxicol. Appl. Pharmacol. 87 1987 185 205
6. I. Astrand Effect of physical exercise on uptake, distribution and elimination of vapors in man V. Fiserova-Bergerova Modeling of Inhalation Exposure to Vapor: Uptake, Distribution, and Elimination 1983 CRC Press Boca Raton, Florida 107 130
7. G.B. Barnes, G.P. Daston, and J.S. Evans Benchmark dose workshop: Criteria for use of a benchmark dose to estimate a reference dose Regul. Toxicol. Pharmacol. 21 1995 296 306
8. M. Dourson Uncertainty factors in noncancer risk assessment Regul. Toxicol. Pharmacol. 24 1996 107
9. EC, 1996. Council Directive 96/82/EC of 9 December 1996 on the control of major-accident hazards involving dangerous substances (Official Journal L 010 of 14 January 1997 pp. 0013-0033).
10. EPA, 1994. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry. EPA/600/8-90/066F, Environmental Criteria and Assessment Office, Office of Research and Development, Research Triangle Park, NC.
11. J.R. Fowles, G.V. Alexeeff, and D. Dodge The use of benchmark dose methodology with acute inhalation lethality data Regul. Toxicol. Pharmacol. 29 1999 262 278
12. M.L. Gargas, H.J. Clewell, and M.E. Andersen Metabolism of inhaled dihalomethanes in vivo: differentiation of kinetic constants for two independent pathways Toxicol. Appl. Pharmacol. 82 1986 211 223
13. D.W. Gaylor Quantalization of continuous data for benchmark dose estimation Regul. Toxicol. Pharmacol. 24 1996 246 250
14. D.W. Gaylor, R.L. Kodell, J.J. Chen, and D. Krewski A unified approach to risk assessment for cancer and noncancer endpoints based on benchmark doses and uncertainty/safety factors Regul. Toxicol. Pharmacol. 29 1999 151 157
15. D.W. Gaylor, L. Ryan, D. Krewski, and Y. Zhu Procedures for calculating benchmark doses for health risk assessment Regul. Toxicol. Pharmacol. 28 1998 150 164
16. U. Gundert-Remy, and C. Sonich-Mullin The use of toxicokinetic and toxicodynamic data in risk assessment: an international perspective Sci. Total Environ. 288 2002 3 11
17. F. Haber Zur Geschichte des Gaskrieges F. Haber Fünf Vorträge aus den Jahren 1920-1923 1924 Springer-Verlag Berlin 76 92
18. N.H. Holford, and L.B. Sheiner Pharmacokinetic and pharmacodynamic modeling in vivo CRC Crit. Rev. Bioeng. 5 1981 273 322
19. G. Johanson Modeling of respiratory exchange of polar-solvents Ann. Occup. Hyg. 35 1991 323 339
20. W.J. Jusko, and H.C. Ko Physiologic indirect effect models characterize diverse types of pharmacodynamic effect Clin. Pharm. Ther. 56 1995 406 419
21. W. Leisenring, and L. Ryan Statistical properties of the NOAEL Regul. Toxicol. Pharmacol. 15 1992 161 171
22. M.E. Meek, R. Newhook, R.G. Liteplo, and V.C. Armstrong Approach to assessment of risk to human health for priority substances under the Canadian Environmental Protection Act. Environ. Carcinogen. Ecotoxicol. Rev. 12 1994 105 134
23. NRC Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals 2001 National Academy Press Washington, DC
24. NRC Guidelines for Developing Community Emergency Exposure Levels for Hazardous Substances. 1993 National Academy Press Washington, DC
25. R.H. Reitz, S.M. Hays, and M.L. Gargas Addressing Priority Data Needs for Methylene Chloride with Physiologically Based Pharmacokinetic Modeling 1997 Agency for Toxic Substances and Disease Registry Atlanta, GA
26. A.G. Renwick Data-derived safety factors for the evaluation of food additives and environmental contaminants Food Addit. Contam. 10 1993 275 305
27. W.E. Rinehart, and T. Hatch Concentration-time product (CT) as an expression of dose in sublethal exposures of phosgene Am. Ind. Hyg. Assoc. J. 25 1964 545 553
28. W.F. ten Berge, A. Zwart, and L.M. Appelman Concentration-time mortality response relationship of irritant and systemically acting vapors and gases J. Hazard. Mater. 13 1986 301 309
29. I. Vieira, M. Sonnier, and T. Cresteil Developmental expression of CYP2E1 in the human liver - hypermethylation control of gene expression during the neonatal period Eur. J. Biochem. 238 1996 476 483